
Ceftazidime-avibactam is highly efficacious against extensive- and multidrug-resistant strains of Mycobacterium tuberculosis .
Dose-Response Relationship, Drug, Extensively Drug-Resistant Tuberculosis, Age Factors, Antitubercular Agents, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Ceftazidime, Cell Line, Drug Combinations, Treatment Outcome, Mutation, Tuberculosis, Multidrug-Resistant, Animals, Humans, Azabicyclo Compounds, Research Articles, Genome, Bacterial
Dose-Response Relationship, Drug, Extensively Drug-Resistant Tuberculosis, Age Factors, Antitubercular Agents, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Ceftazidime, Cell Line, Drug Combinations, Treatment Outcome, Mutation, Tuberculosis, Multidrug-Resistant, Animals, Humans, Azabicyclo Compounds, Research Articles, Genome, Bacterial
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 63 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
